These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 19935523)
21. Calcium and phosphorus metabolism in patients who have chronic kidney disease. Goodman WG Med Clin North Am; 2005 May; 89(3):631-47. PubMed ID: 15755471 [TBL] [Abstract][Full Text] [Related]
22. [Monostatic localization of bone dystrophy in patients under hemodialysis for chronic renal insufficiency]. Noè C Arch Ital Urol Nefrol; 1971; 43(4):251-7. PubMed ID: 5130445 [No Abstract] [Full Text] [Related]
23. [Thyroparathyroidectomized dogs. Calcium and magnesium perfusion tests and study of calcium and magnesium kinetics using Ca 47 and Mg 28 ]. Monsaingeon A; Raynaud C; Balan L; Thomas J C R Seances Soc Biol Fil; 1972; 166(1):43-8. PubMed ID: 4640413 [No Abstract] [Full Text] [Related]
25. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed]. Houillier P; Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626 [No Abstract] [Full Text] [Related]
31. [Diffuse decalcifying osteosis in hyperthyroidism (apropos of 2 male case)]. Wemeau J; Gras E; Grenier JL; Cordier R; Flamencourt P; Wemeau JL Lille Med; 1980 Oct; 25(8):433-7. PubMed ID: 7442436 [No Abstract] [Full Text] [Related]
32. Disorders of calcium and phosphate metabolism in childhood and adolescence. Harrison HE; Harrison HC Major Probl Clin Pediatr; 1979; 20():1-314. PubMed ID: 491744 [No Abstract] [Full Text] [Related]
33. Association of disorders in mineral metabolism with progression of chronic kidney disease. Schwarz S; Trivedi BK; Kalantar-Zadeh K; Kovesdy CP Clin J Am Soc Nephrol; 2006 Jul; 1(4):825-31. PubMed ID: 17699293 [TBL] [Abstract][Full Text] [Related]
34. Calcium and phosphorus derangements. Yucha CB; Toto KH Crit Care Nurs Clin North Am; 1994 Dec; 6(4):747-66. PubMed ID: 7766351 [TBL] [Abstract][Full Text] [Related]
35. [New ideas concerning the role of the parathyroid hormone and vitamin D in disorders of phosphocalcic metabolism]. Corvilain J; Brauman H; Manderlier T; Fuss M Brux Med; 1975 Jan; 55(1):7-16. PubMed ID: 1116034 [No Abstract] [Full Text] [Related]
36. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment]. Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577 [TBL] [Abstract][Full Text] [Related]
37. [Osseous effects of hyperthyroidism]. Bianchi GS; Meunier P; Courpron P; Edouard C; Bernard J; Vignon G Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):19-32. PubMed ID: 4342875 [No Abstract] [Full Text] [Related]
38. [Anabolizing agents and phosphocalcic metabolism]. Eisinger J; D'Omezon Y; Laponche AM; Recordier AM Mars Med; 1972; 109(1):31-3. PubMed ID: 5018830 [No Abstract] [Full Text] [Related]
39. [Statements on the role of the parathyroid glands in bone metastases]. Less E Endokrinologie; 1966 Aug; 50(3):122-30. PubMed ID: 5998872 [No Abstract] [Full Text] [Related]
40. Biomicroscopy of the anterior eye segment in chronic renal failure. Szmigielski M; Gradowska L; Komitowski D Pol Med J; 1970; 9(1):51-4. PubMed ID: 5437042 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]